p21 gene codon 31 polymorphism is associated with bladder cancer
- 12 March 2002
- journal article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 7 (2) , 63-66
- https://doi.org/10.1016/s1078-1439(01)00152-1
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- WAF1/p21 Protein Expression Is an Independent Prognostic Indicator in Superficial and Invasive Bladder CancerApplied Immunohistochemistry & Molecular Morphology, 2000
- Distributions of p53 codon 72 polymorphism in bladder cancer - proline form is prominent in invasive tumorUrological Research, 2000
- POLYMORPHISMS OF N-ACETYLTRANSFERASE 2, GLUTATHIONE S-TRANSFERASE MU AND THETA GENES AS RISK FACTORS OF BLADDER CANCER IN RELATION TO ASTHMA AND TUBERCULOSISJournal of Urology, 2000
- p21WAF–1/CIP–1, a Downstream Regulator of Functional p53 Loss, in Transitional Cell Carcinoma of UrotheliumEuropean Urology, 2000
- Glutathione S–Transferase Null Genotypes in Transitional Cell Bladder CancerEuropean Urology, 2000
- Single nucleotide polymorphism libraries: why and how are we building them?Molecular Medicine Today, 1999
- Genetic variations can point the way to disease genesNature, 1999
- The genetics of transitional cell carcinoma: progress and potential clinical applicationBJU International, 1999
- Variations on a Theme: Cataloging Human DNA Sequence VariationScience, 1997
- p21 is a universal inhibitor of cyclin kinasesNature, 1993